Introduction: Tumor-derived free-circulating DNA in peripheral blood allows the study of the molecular genetic profile in cholangiocarcinomas and even the effective monitoring of the response to chemotherapy.
Objective: The use of a liquid biopsy is a favourable solution, as repeated invasive histological sampling is much more practicable and avoidable. The efficiency of liquid biopsy-based sequencing increases with tumor progression and thus with the release of larger amounts of free DNA.
Method: In the present study, clinically relevant point mutations were detected from both histological and liquid biopsy specimens of bile duct tumors.
Results: During next-generation sequencing, histological and DNA samples obtained during liquid biopsy from 33 patients were analyzed using a 67-gene solid tumor panel.
Discussion: In our prospective study, we present a minimally invasive approach to identify molecular genetic changes in cholangiocarcinoma and gallbladder tumors.
Conclusion: The diagnostic application of free DNA reflects the spatial heterogeneity of tumors, making it a new approach to precision oncology treatments. Orv Hetil. 2022; 163(50): 1982-1991.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1556/650.2022.32651 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!